| For: | Ali FE, Abd El-Aziz MK, Sharab EI, Bakr AG. Therapeutic interventions of acute and chronic liver disorders: A comprehensive review. World J Hepatol 2023; 15(1): 19-40 [PMID: 36744165 DOI: 10.4254/wjh.v15.i1.19] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v15/i1/19.htm |
| Number | Citing Articles |
| 1 |
Nashwa Hafez Zaher, Mohamed Ismail Mostafa, Marwa Galal El-Gazzar. Design and synthesis of new curcumin analogues as hepatoprotectives and antioxidants in liver dysfunction through caspase-3 regulation. Future Medicinal Chemistry 2026; 18(13) doi: 10.1080/17568919.2026.2676783
|
| 2 |
Qiuyun Yi, Jinxian Yang, Ying Wu, Ying Wang, Qiqi Cao, Wen Wen. Immune microenvironment changes of liver cirrhosis: emerging role of mesenchymal stromal cells. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1204524
|
| 3 |
Jitendra Patel, Harekrishna Roy, Deepak S. Khobragade, Surendra Agrawal, Nihar Ranjan Das, Rukmani Patel, Vijay Patel, Poonam Lal. Natural lipid-based nanoformulations for enhancing hepatoprotective activity: mechanisms, efficacy, and clinical translation. Health Nanotechnology 2025; 1(1) doi: 10.1186/s44301-025-00010-8
|
| 4 |
Aneta Sokal-Dembowska, Sara Jarmakiewicz-Czaja, Rafał Filip. Flavonoids and Their Role in Preventing the Development and Progression of MAFLD by Modifying the Microbiota. International Journal of Molecular Sciences 2024; 25(20) doi: 10.3390/ijms252011187
|
| 5 |
Zaid F. AL-rasheedi, Omnia A. Nour, Dalia H. El-Kashef. Vonoprazan mitigates diethyl nitrosamine-induced acute liver injury in mice via modulating p-AMPK/ SIRT1/ PGC-1α and Keap1/Nrf2/HO-1 pathways. Life Sciences 2026; 392 doi: 10.1016/j.lfs.2026.124314
|
| 6 |
Gehad Nasr, Doaa Mohamed Elroby Ali, Michael A. Fawzy, Fares E.M. Ali, Moustafa Fathy. Combined quercetin with phosphodiesterase inhibitors; sildenafil and pentoxifylline alleviated CCl4-induced chronic hepatic fibrosis: Role of redox-sensitive pathways. Food and Chemical Toxicology 2025; 201 doi: 10.1016/j.fct.2025.115442
|
| 7 |
Neha Kanojia, Komal Thapa, Thakur Gurjeet Singh, Nitin Verma. Exosomes: A promising drug delivery tool in hepatic drug delivery. Journal of Drug Delivery Science and Technology 2025; 107 doi: 10.1016/j.jddst.2025.106761
|
| 8 |
Shagun Sanjivv Dogra, Vikram Patial. Iridoids in liver diseases: Mechanistic insights and molecular mechanism. Journal of Integrative Medicine 2026; 24(3) doi: 10.1016/j.joim.2026.01.008
|
| 9 |
Martí Ortega-Ribera. Learning about liver regeneration from liver-on-a-chip. Current Opinion in Biomedical Engineering 2024; 30 doi: 10.1016/j.cobme.2024.100533
|
| 10 |
Kunyu Wei, Shan He, Xingyu Guo, Siyi Li, Junjie Wang, Xiaolei Wang, Jia He, Fengchang Wu. Developmental hepatotoxicity of liquid crystal monomers in zebrafish: hepatic lipid accumulation and metabolic disruption. Environmental Chemistry and Ecotoxicology 2026; doi: 10.1016/j.enceco.2026.10.005
|
| 11 |
Tea Omanovic Kolaric, Lucija Kuna, Marina Covic, Hrvoje Roguljic, Anita Matic, Renata Sikora, Marija Hefer, Ana Petrovic, Vjera Mihaljevic, Robert Smolic, Ines Bilic-Curcic, Aleksandar Vcev, Martina Smolic. Preclinical Models and Promising Pharmacotherapeutic Strategies in Liver Fibrosis: An Update. Current Issues in Molecular Biology 2023; 45(5) doi: 10.3390/cimb45050270
|
| 12 |
Lilly Josephine Bindel, Roland Seifert. Problems associated with the ATC system of drug classification. Naunyn-Schmiedeberg's Archives of Pharmacology 2026; 399(5) doi: 10.1007/s00210-025-04833-1
|
| 13 |
Trilochan Satapathy, Mansi Verma, Poonam Sahu, Anjali Minj. Therapeutic potential of gallic acid and diosgenin in metabolic dysfunction-associated steatotic liver disease (MASLD) and non-alcoholic fatty liver disease (NAFLD): A comprehensive review. Pharmacological Research - Natural Products 2026; 10 doi: 10.1016/j.prenap.2026.100525
|